AnalystsSami CorwinSami Corwin's Stock Forecasts
AnalystsSami Corwin
Sectors:
Industries:
Analyst Ranking
Top 43%
#2110 out of 4929 analysts
Average Return
+18.72%
Win Rate
50%2 out of 4
Risk vs Reward
Poor
Good
Sami Corwin's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Akouos IncAKUS | +110.32% | $6.30 | $13.25 | 2022-09-29 - 2022-10-19 | Buy |
Ultragenyx Pharmaceutical IncRARE | +16.19% | $34.35 | $39.91 | 2025-05-28 - 2025-07-03 | Buy |
Sami Corwin Analyst Color
Get additional color on Sami Corwin's coverage of popular stocks
Sami Corwin's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical IncRARE | 1 | Buy | $65.00 | +62.87% | Initiates Coverage On | a month ago |
Crispr Therapeutics AgCRSP | 1 | Buy | $75.00 | N/A | Reinstates | 2 years ago |
Akouos IncAKUS | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Uniqure NvQURE | 1 | Buy | $66.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.